Interventional device developer Boston Scientific of Natick, MA, has completed the sale of its cardiac surgery and vascular surgery businesses to a Swedish investment group.
Boston Scientific sold the divisions to Getinge Group for $750 million after announcing the deal in November. The company said it would incur after-tax charges of $240 million in connection with the sale of the businesses.
Boston Scientific said that it has now sold three of the five businesses that don't fit with the company's new long-term strategy. It plans to complete the sale of the remaining two businesses -- fluid management and venous access -- during the current fiscal quarter.
Related Reading
Boston Scientific to spin off businesses, December 14, 2007
Boston Scientific, GE complete EMR integration, November 7, 2007
Boston Scientific receives Cordis litigation verdict, November 2, 2007
Boston Scientific to lay off 2,300, October 18, 2007
Boston Scientific amends credit, prepays loan, August 23, 2007
Copyright © 2008 AuntMinnie.com
